Article
DCC constrains tumour progression via its dependence receptor activity.
Nature - 11 Dec 2011
Castets Marie, Broutier Laura, Molin Yann, Brevet Marie, Chazot Guillaume, Gadot Nicolas, Paquet Armelle, Mazelin Laetitia, Jarrosson-Wuilleme Loraine, Scoazec Jean-Yves, Bernet Agnès, Mehlen Patrick
Abstract excerpt
The role of deleted in colorectal carcinoma (DCC) as a tumour suppressor has been a matter of debate for the past 15 years. DCC gene expression is lost or markedly reduced in the majority of advanced colorectal cancers and, by functioning as a dependence receptor, DCC has been shown to induce apoptosis unless engaged by its ligand, netrin-1 (ref. 2). However, so far no animal model has supported the view that the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
